Assembly Biosciences, Inc. announced that Luisa Stamm, MD, PhD, the current Assembly Bio chief medical officer, will leave the company at the end of this month. Michele Anderson, SVP of development operations at Assembly Bio, has been appointed as chief development officer effective August 1, 2022, and will assume responsibility for the company's development organization. Jason Okazaki, Assembly Bio's current chief operating officer, will oversee all general and administrative functions, including finance.

Due to these increased departmental responsibilities, Mr. Okazaki has been appointed as president and chief operating officer effective August 1, 2022.